Page 221 - HIV/AIDS Guidelines

CNICS Centers for AIDS Research Network of Integrated Clinical Systems

CNS central nervous system
COC combined oral contraceptive
CPK creatine phosphokinase
CrCl creatinine clearance

CSF cerebrospinal fluid
CVD cardiovascular disease
CYP cytochrome P

d4T stavudine
D:A:D Data Collection on Adverse Events of Anti-HIV Drugs Study

ddC zalcitabine
ddI didanosine
DHHS Department of Health and Human Services
DILI drug-induced liver injury

DLV delavirdine
DM diabetes mellitus
D/M dual or mixed (tropic)
DMPA depot-medroxyprogesterone acetate
DOT directly observed therapy
DR delayed release

DRV darunavir
DRV/r darunavir/ritonavir
DXA dual-energy x-ray absorptiometry

EBV Epstein-Barr virus
EC enteric coated
ECG electrocardiogram
EFV efavirenz
EFV/FTC/TDF efavirenz + emtricitabine + tenofovir disoproxil fumarate
EI entry inhibitor

EIA enzyme immunoassay
ETR etravirine

FDA Food and Drug Administration

FI fusion inhibitor
FPV fosamprenavir
FPV/r fosamprenavir/ritonavir
FTC emtricitabine

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents N-2

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.